Nath Bio-Genes (India) Limited (BOM:537291)

Market Cap	2.61B -9.6%
Revenue (ttm)	4.46B +25.1%
Net Income	431.20M +12.8%
EPS	22.69 +13.7%
Shares Out	n/a
PE Ratio	6.06
Forward PE	n/a
Dividend	2.00 (1.57%)
Ex-Dividend Date	Aug 14, 2025

Volume	1,902
Average Volume	4,509
Open	134.95
Previous Close	127.65
Day's Range	134.70 - 139.00
52-Week Range	126.75 - 238.00
Beta	n/a
RSI	48.54
Earnings Date	Apr 24, 2026

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising cabbage, chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas,...

• Industry: Agricultural Production Crops
• Founded: 1979
• Employees: 451
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 537291

Financial Performance

In fiscal year 2025, Nath Bio-Genes (India)'s revenue was 3.65 billion, an increase of 9.70% compared to the previous year's 3.33 billion. Earnings were 386.00 million, a decrease of -2.57%.